Masaki Shimbo

Dr. Masaki Shimbo

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2020 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
MSMasaki Shimbo
Masaki Shimbo
FEFumiyasu Endo
Fumiyasu Endo
KMKazuhito Matsushita
Kazuhito Matsushita
KHKazunori Hattori
Kazunori Hattori

1 July 2004 in Journal of Urology
Verified
Journal Article
Closed access
MSMasaki Shimbo
Masaki Shimbo
KAKazuhiro Araki
Kazuhiro Araki
TKToshimitsu Kaibuchi
Toshimitsu Kaibuchi
HKHiroaki Kuramochi
Hiroaki Kuramochi
IMIkuo Mori
Ikuo Mori

6 March 2013 in Urologia Internationalis
Verified
Journal Article
Closed access
PDF file
MSMasaki Shimbo
Masaki Shimbo
KIKoichi Inoue
Koichi Inoue
YKYusuke Koike
Yusuke Koike
SKSusumu Katano
Susumu Katano
KKKiyotaka Kawashima
Kiyotaka Kawashima
Introduction: Although radiotherapy has been important in the therapy for localized prostate cancer, prostate-specific antigen failure may occur. This study evaluated the effects and side effects of 125I low-dose-rate brachytherapy for patients with postradiation local failure. Patients and Methods: 15 patients who received salvage brachytherapy were analyzed. A prescribed dose of 144 Gy was selected. Median follow-up calculated from the date of salvage brachytherapy was 33.0 months (range 6-51). Results: 5 patients (33.3%) developed prostate-specific antigen failure. The biochemical relapse-free survival rate was 100% at 1 year, 91.7% at 2 years, and 60.2% at 3 years. All acute genitourinary and gastrointestinal adverse events were in grade 1-2 according to Common Terminology Criteria for Adverse Events version 3. As for late adverse events, 1 patient (6.7%) developed grade 3 hematuria at 17 months postsalvage. Conclusions: Although careful patient selection is needed, salvage 125I prostate brachytherapy appears to provide good prostate cancer control with an acceptable rate of complications for patients with local recurrence of prostate cancer after initial radiotherapy.

4 January 2024 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Open access
ITIchiro Takemasa
Ichiro Takemasa
AHAtsushi Hamabe
Atsushi Hamabe
ATAtsushi Takenaka
Atsushi Takenaka
HKHiroaki Kobayashi
Hiroaki Kobayashi
MMMasaki Mandai
Masaki Mandai
MWMasahiko Watanabe
Masahiko Watanabe
Background: Pelvic lymph node dissection is a procedure performed in gastroenterological surgery, urology, and gynecology. However, due to discrepancies in the understanding of pelvic anatomy among these departments, cross‐disciplinary discussions have not been easy. Recently, with the rapid spread of robotic surgery, the importance of visual information in understanding pelvic anatomy has become even more significant. In this project, we attempted to clarify a shared understanding of pelvic anatomy through cross‐disciplinary discussions.Method: From May 2020 to November 2021, a total of 11 discussions were held entirely online with 5 colorectal surgery specialists, 4 urologists, and 4 gynecologists. The discussions focused on evidence from each specialty and surgical videos, aiming to create a universally understandable pelvic anatomical illustration.Results: The common area of dissection recognized across the three departments was identified as the obturator lymph nodes. A dynamic illustration of pelvic anatomy was created. In addition to a bird's‐eye view of the pelvis, a pelvic half view was developed to enhance understanding of the deeper pelvic anatomy. The following insights were incorporated into the illustration: (1) the cardinal ligament in gynecology partly overlaps with the vesicohypogastric fascia in colorectal surgery; (2) the obturator lymph nodes continue cephalad into the fossa of Marcille in urology; and (3) the deep uterine vein in gynecology corresponds to the inferior vesical vein in colorectal surgery.Conclusion: Based on the dynamic illustration of pelvic anatomy from cross‐disciplinary discussions, we anticipate advancements in pelvic lymph node dissection aiming for curative and safe outcomes.

7 August 2024 in International Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
NHNobuyki Hinata
Nobuyki Hinata
SMSae Murakami
Sae Murakami
YNYuzo Nakano
Yuzo Nakano
IHIsao Hara
Isao Hara
TKTsunenori Kondo
Tsunenori Kondo
MFMasato Fujisawa
Masato Fujisawa
Background: This study aimed to compare the efficacy of robot-assisted partial nephrectomy for completely endophytic renal tumors with the reported outcomes of conventional laparoscopic partial nephrectomy and investigate the transition of renal function after robot-assisted partial nephrectomy. Methods: We conducted a prospective, multicenter, single-arm, open-label trial across 17 academic centers in Japan. Patients with endophytic renal tumors classified as cT1, cN0, cM0 were included and underwent robot-assisted partial nephrectomy. We defined two primary outcomes to assess functional and oncological aspects of the procedure, which were represented by the warm ischemic time and positive surgical margin, respectively. Comparisons were made using control values previously reported in laparoscopic partial nephrectomy studies. In the historical control group, the warm ischemia time was 25.2, and the positive surgical margin was 13%. Results: Our per-protocol analysis included 98 participants. The mean warm ischemic time was 20.3 min (99% confidence interval 18.3–22.3; p < 0.0001 vs. 25.2). None of the 98 participants had a positive surgical margin (99% confidence interval 0–5.3%; p < 0.0001 vs. 13.0%). The renal function ratio of eGFR before and after protocol treatment multiplied by splits was 0.70 (95% confidence interval: 0.66–0.75). Factors such as preoperative eGFR, resected weight, and warm ischemic time influenced the functional loss of the partially nephrectomized kidney after robot-assisted partial nephrectomy. Conclusions: Robot-assisted partial nephrectomy for completely endophytic renal tumors offers a shorter warm ischemia time and comparable positive surgical margin rate compared with conventional laparoscopic partial nephrectomy.

24 August 2022 in International Journal of Urology
Verified
Journal Article
Closed access
MSMasaki Shimbo
Masaki Shimbo
FEFumiyasu Endo
Fumiyasu Endo
TMTaketo Matsubara
Taketo Matsubara
GSGen Shimada
Gen Shimada
KHKazunori Hattori
Kazunori Hattori